Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetes

Trial Profile

Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetes

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Jun 2014

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DIAB-therapy
  • Most Recent Events

    • 22 Jul 2012 Actual initiation date (Dec 2011) added as reported by University Hospital Medical Information Network - Japan.
    • 06 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top